Familial Mediterranean fever in which Crohn’s disease was suspected: a case report

BMC Research Notes

Yukio Yoshida¹  Shunsuke Urayoshi¹  Satohiro Matsumoto¹ 

[1] Department of Gastroenterology, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma, Omiya, Saitama, Saitama 330-8503, Japan

关键词: Crohn’s disease;    Colchicine;    Autoinflammatory disease;    Familial Mediterranean fever;   

Others  :  1127397
DOI  :  10.1186/1756-0500-7-678

 received in 2014-03-27, accepted in 2014-09-23,  发布年份 2014

【 摘 要 】

Background

Familial Mediterranean fever is a hereditary autoinflammatory disease, mainly characterized by periodic fever and serositis. The level of awareness about familial Mediterranean fever is far from sufficient, and it is assumed that there may be many patients with this disease who are under observation without an accurate diagnosis.

Case presentation

A 30-year-old Japanese man presented to us with a few years’ history of recurrent episodes of fever, abdominal pain and diarrhea. He often visited a hospital when the attacks occurred; however, acute enteritis was diagnosed each time, and the symptoms resolved spontaneously within a few days. When he noticed a shortening of the interval between the attacks, he visited the hospital again. Upper endoscopy and colonoscopy performed at this hospital revealed no significant abnormal findings. He was then referred to our hospital under the suspicion of a small intestinal disease. Abdominal computed tomography revealed wall thickening and increased density of the mesenteric adipose tissue in the jejunum, which led us to suspect Crohn’s disease. Oral double-balloon enteroscopy was performed; because this revealed only mild mucosal edema in the jejunum, Crohn’s disease was considered to be highly improbable. Based on the patient’s clinical course, we suspected familial Mediterranean fever. As the Livneh criteria for familial Mediterranean fever were satisfied, the patient was started on oral colchicine for the purpose of diagnostic treatment. A definitive diagnosis of familial Mediterranean fever was then made based on the detection of a mutation of the Mediterranean fever gene. A marked reduction in the frequency of attacks was observed in response to colchicine treatment.

Conclusions

Although Crohn’s disease may be considered first in the differential diagnosis of young patients presenting with periodic fever, abdominal pain and diarrhea, the possibility of familial Mediterranean fever should also be borne in mind.

【 授权许可】

   
2014 Matsumoto et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Janeway TC, Mosenthal HO: An unusual paroxysmal syndrome, probably allied to recurrent vomiting, with a study of the nitorogen metabolism. Trans Ass Am Phys 1908, 23:504-518.
• [2]Onen F: Familial Mediterranean fever. Rheumatol Int 2006, 26:489-496.
• [3]Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M: Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997, 40:1879-1885.
• [4]Hayashi A, Suzuki T, Shimizu A, Yamamura Y: Letter: Periodic fever suppressed by reserpine. Lancet 1976, 1:592.
• [5]Migita K, Agematsu K: Clinical aspects of Familial Mediterranean fever. Jpn J Clin Immunol 2011, 34:355-360. in Japanese, Abstract in English
• [6]Fidder HH, Chowers Y, Lidar M, Sternberg M, Langevitz P, Livneh A: Crohn disease in patients with familial Mediterranean fever. Medicine 2002, 81:411-416.
• [7]Ghaffar TYA, Elsayed SM: Colchicine resistant FMF is not always true resistance. Egypt J Med Hum Genet 2011, 12:99-101.
• [8]Kuloğlu Z, Kansu A, Ustündağ G, Birsin Özçakar Z, Ensari A, Ekim M: An infant with severe refractory Crohn's disease and homozygous MEFV mutation who dramatically responded to colchicine. Rheumatol Int 2012, 32:783-785.
• [9]Tsuchiya-Suzuki A, Yazaki M, Nakamura A, Yamazaki K, Agematsu K, Matsuda M, Ikeda S: Clinical and genetic features of familial Mediterranean fever in Japan. J Rheumatol 2009, 36:1671-1676.
• [10]Booth DR, Gillmore JD, Lachmann HJ, Booth SE, Bybee A, Soytürk M, Akar S, Pepys MB, Tunca M, Hawkins PN: The genetic basis of autosomal dominant familial Mediterranean fever. QJM 2000, 93:217-221.
• [11]Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J: Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 1986, 314:1001-1005.
• [12]Dinarello CA, Wolff SM, Goldfinger SE, Dale DC, Alling DW: Colchicine therapy for familial mediterranean fever. A double-blind trial. N Engl J Med 1974, 291:934-937.
• [13]Goldstein RC, Schwabe AD: Prophylactic colchicine therapy in familial Mediterranean fever. A controlled, double-blind study. Ann Intern Med 1974, 81:792-794.
• [14]Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E, Ozen S, Topaloglu R, Yilmaz E, Arici M, Bakkaloglu A, Besbas N, Akpolat T, Dinc A, Erken E, Turkish FMF Study Group: Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 2005, 84:1-11.
• [15]Ben-Chetrit E: Familial Mediterranean fever (FMF) and renal AA amyloidosis-phenotype-genotype correlation, treatment and prognosis. J Nephrol 2003, 16:431-434.